Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04419480 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial

Study acronym: HALO-Shock
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Dec 31, 2026 to Dec 31, 2028v8
  2. Re-verified, no change to tracked fieldsv7
  3. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v6
  4. Primary and study completion dates: Dec 31, 2022 to Dec 31, 2026
    • Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v5
  5. Primary completion date: Sep 1, 2021 to Dec 31, 2022
    • Study completion date: Sep 1, 2022 to Dec 31, 2022
    v4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Sep 1, 2020 to Dec 31, 2020
    • Site details revised
    v3
  2. Start date: Jun 1, 2020 to Sep 1, 2020
    • Primary completion date: Dec 1, 2021 to Sep 1, 2021
    • Study completion date: Jun 1, 2022 to Sep 1, 2022
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Pilot Prospective Randomized Unblinded Pragmatic Trial of Pulmonary Artery Hemodynamic Monitoring Following Hospitalization for Cardiogenic Shock
Trial Details
NCT Number NCT04419480
Lead Sponsor Inova Health Care Services
Collaborators: Abbott
Conditions
(from sponsor)		 Cardiogenic Shock, Heart Failure, Ambulatory Hemodynamic Monitoring
Related terms Heart Failure, Shock, Cardiogenic
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov